Quantcast
Last updated on April 16, 2014 at 11:49 EDT

Latest E2 Stories

2012-04-18 22:21:29

HOERSHOLM, Denmark and SAN DIEGO, April 19, 2012 /PRNewswire/ -- Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, will present final data from a Phase 2a trial showing that miravirsen given as a four-week monotherapy treatment provided robust dose-dependent anti-viral activity with a mean reduction of 2 to 3 logs from baseline in HCV RNA (log10 IU/mL) that was sustained well beyond the end of therapy. These...

2012-04-14 23:02:56

The new documentary film opens nationally today. CHARLOTTE, N.C. and LOS ANGELES, Calif., (PRWEB) April 13, 2012 Jackie Fame, Inc. (FAME), the leading kid/teen social network http://www.JFame.com, is joining forces with The Weinstein Company to promote the movie “Bully.” After much debate over the rating, the PG-13 version of the anti-bullying documentary will open in 115 theaters. FAME and the AMC Cinema chain will sponsor several “Bully Movie Events” across the...

2011-09-26 15:00:00

CompassBiotech Making Drugs to Combat Major Human Diseases EDMONTON, Sept. 26, 2011 /PRNewswire/ - Compass (COBI:OB) is pleased to announce new research findings that it believes will alter the course of HCV vaccine development and other vaccines in general. Vaccine products continue to be the success story for pharmaceutical companies, with the world market for preventative vaccines in 2010 being $ 28 billion as compared to $26 billion in 2009, $24 billion in 2008 and $18.5...

2011-06-23 15:31:21

NewYork-Presbyterian/Weill Cornell physician-scientist leads study reporting that FDA-approved telaprevir-based regimen acts faster and offers a stronger viral cure than standard treatment The drug telaprevir (Incivek) provides a dramatic improvement in the treatment of the most common form of hepatitis C infection, says an international team of investigators led by Dr. Ira M. Jacobson of NewYork-Presbyterian Hospital/Weill Cornell Medical Center. Their study, published in today's edition of...

2011-05-09 08:15:00

SAN DIEGO, May 9, 2011 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD) announces that it has submitted a request to the U.S. Food and Drug Administration (FDA) for a face-to-face meeting to discuss re-initiation of an Investigational Device Exemption (IDE) study of the Aethlon Hemopurifier® in the United States. As part of these discussions, Aethlon management will present FDA officials with new clinical data that supports the safety of the...

2009-12-09 09:17:00

GAITHERSBURG, Md,, Dec. 9 /PRNewswire/ -- Lentigen Corporation, a biotechnology company specializing in the development and manufacture of lentiviral gene delivery technologies, announced today that it has received a National Institutes of Health (NIH) small business innovation research (SBIR) grant for a program on "A Novel Method of Generating Hepatitis C Virus-Like Particles using Lentivirus". In this program, Lentigen will collaborate with Epixis SA (Paris, France). The Hepatitis C...

2009-08-10 16:07:55

Japanese scientists say they've discovered a chemical found in blueberry leaves can help block the replication of the hepatitis C virus. The researchers, led by Hiroaki Kataoka and colleagues at the University of Miyazaki, said the discovery opens a new avenue for treating chronic hepatitis C infections. Currently, there is no vaccine for HCV, and although a combination drug regimen can clear HCV infection, the scientists said that treatment is only about 60 percent effective and poses risks...

2008-07-04 03:00:06

By Liang, Shu-Ling Hepatocyte injury, commonly encountered in the practice of medicine, can be caused by a number of diseases such as hepatitis, autoimmune disorders, and congenital or acquired disorders of metabolism, or by exposure to alcohol, chemicals, and drugs. The most common cause of liver injury worldwide is infection with viruses that primarily infect the liver, often termed hepatitis viruses. Viral infections are the most common cause of acute hepatitis. The range of responsible...

2005-06-09 20:22:37

A team of researchers led by scientists at The Rockefeller University has produced for the first time an infectious form of the hepatitis C virus (HCV) in laboratory cultures of human cells. The finding, reported in the June 9 issue of Science Express, will allow scientists to study every stage of the HCV life cycle and develop drugs to treat this life-threatening disease that affects more than 170 million people around the world. "The inability to reproduce aspects of the hepatitis C virus...


Latest E2 Reference Libraries

Astropecten platyacanthus
2012-04-19 09:07:55

Gorgonocephalus eucnemis is a species of starfish found in circumpolar marine environments in the Northern Hemisphere, particularly the Arctic Ocean and northern parts of the Atlantic Ocean as far south as the Faeroe Islands and Massachusetts Bay. It also occurs in the Pacific Ocean from the Bering Sea south to Japan and Laguna Beach, California. It is found in rocky areas with strong currents at depths down to 6,600 feet, but more commonly at 50 to 500 feet. It is also found on mud and sandy...

More Articles (1 articles) »